SignalRx Pharmaceuticals, Inc.
Records under this name other than the patents SignalRx Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 9 patents it holds.
Showing 1 to 4 of 4 · Back to SignalRx Pharmaceuticals, Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,981,983 | Thienopyranones as kinase inhibitors Lapsed on the fee record Ended May 29, 2026 · USPTO record | Lapsed on the fee record | Ended May 29, 2026 | USPTO record |
| US 7,662,977 | PI-3 kinase inhibitor prodrugs Lapsed on the fee record Ended Feb 16, 2022 · USPTO record | Lapsed on the fee record | Ended Feb 16, 2022 | USPTO record |
| US 7,396,828 | PI-3 kinase inhibitor prodrugs Lapsed on the fee record Ended Jul 8, 2016 · USPTO record | Lapsed on the fee record | Ended Jul 8, 2016 | USPTO record |
| US 6,949,537 | PI-3 kinase inhibitor prodrugs Lapsed on the fee record Ended Sep 27, 2013 · USPTO record | Lapsed on the fee record | Ended Sep 27, 2013 | USPTO record |